CD274 and neoplasm: Generally, tumors with the presence of tumor infiltrated lymphocytes (TILs), expressions of PD-L1 and tumor-related immune cells, possible genomic instability, and the presence of a pre-existing antitumoral immune response (“hot” tumors) are typically respond well to immunotherapy.